Navigation Links
Experts Say Recommended Daily Dosage for Vitamin D is 'Grossly Inadequate'
Date:5/18/2009

HOUSTON, May 18 /PRNewswire-USNewswire/ -- Current recommendations for Vitamin D were called "grossly inadequate" today at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

"National recommendations from the Food and Nutrition Board are 400 to 600 International Units (IU) a day," Neil Binkley, MD, an Associate Professor in Geriatrics and Endocrinology at the University of Wisconsin said. "That's simply not enough."

"Experts recommend somewhere between 1500 to 2600 IU daily," Dr. Binkley said. "It's considered a very safe vitamin. One would need daily doses of 40,000 IU or higher before seeing negative side effects."

Vitamin D is essential for bone health, but Binkley discussed its role in improving muscle function.

"One of the primary killers among older adults is falls," Binkley said. A sufficient amount of Vitamin D not only enhances bone strength but also improves muscle function thereby reducing the risk of fractures."

Vitamin D receptors have been discovered in many tissues throughout the body. "There's a lot that is unknown about vitamin D right now," Dr. Binkley said. "But there is one certainty - its importance is widespread."

The ubiquitous effects of the "sunshine vitamin" are demonstrated by research studies associating lower circulating vitamin D levels with cancer, type 1 diabetes and cardiovascular disease.

Although young people are perfectly capable of producing vitamin D in their skin after brief exposure to sunlight (10-15 minutes of UVB ray exposure per day), Americans often avoid sun exposure or utilize sunscreen. Additionally, older adults have less ability to produce vitamin D i
'/>"/>

SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2

Related medicine news :

1. Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach
2. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
3. Health IT Event Draws Experts to the Pacific Northwest
4. Experts Sort Out Good Fats From Bad
5. Experts Offer Tips on Lung Cancer Prevention
6. March of Dimes, Experts for Moms and Babies, Launches Podcast
7. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
8. Bay IVF Experts Launch One of First East-West Fertility Programs of Its Kind
9. Experts propose cholesterol tests at 15 months of age
10. Experts Publish New Lung Disease Guidelines
11. Experts, Advocates Available to Comment on Hillary Clintons Health Care Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Researchers at Barrow Neurological Institute at St. Joseph,s ... why the public perceives some magic tricks in ... military tactics, marketing and sports. , Susana Martinez-Conde, ... Stephen Macknik, PhD, of Barrow,s Laboratory of Behavioral ... magic and illusions. Their most recent original research ...
(Date:5/22/2012)... 22, 2012) Scientists at Virginia Commonwealth University ... to developing a new therapy for acute myeloid ... obatoclax and sorafenib kill leukemia cells much more ... administered individually., Recently published in the journal Blood, ... Grant, M.D., Shirley Carter Olsson and Sture Gordon ...
(Date:5/22/2012)... to stray from her breeding partner and mate with ... that sleeping around can be costly. , The 20-year ... found that offspring conceived outside sparrows, social pairs ... offspring. The findings throw a monkey wrench into theories ... cheat. , Most bird species display some form of ...
(Date:5/22/2012)... Medical College of Wisconsin have identified novel biomarkers that ... in large groups of people potentially exposed to unknown ... treatment. , The findings are published in the May ... E. Baker, Ph.D., professor of surgery, biochemistry, pharmacology and ... lead author of the study. , There is an ...
(Date:5/22/2012)... May 22 (HealthDay News) -- Body-building and weight-loss products ... cause liver injury, according to a small new study. ... drugs are taken off the market. Dietary and herbal ... can be bought over the counter or online -- ... in the United States, but their potential side effects ...
Breaking Medicine News(10 mins):Health News:Barrow researchers use magic for discoveries 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:Body Building, Diet Supplements Linked to Liver Damage: Study 2
... COPD Population Will Rise by Nearly 19 Percent as a Result ... from Decision ... Resources, ... leading research and advisory firms for pharmaceutical and,healthcare issues, finds that ...
... shelter for virus out of reach of drugs , , ... a certain type of cell provides a "hideout" for HIV ... humans. , These follicular dendritic cells (FDCs) are located throughout ... researchers at Brigham Young University and Johns Hopkins School of ...
... healthcare system better understand where to focus ... it offers, CAMBRIDGE, MA, May 28 /PRNewswire/ ... and safety software that helps organizations manage,infection control ... medical incidents, claims and quality issues,announced today that ...
... Glycoproducts International,Inc., a provider of nutritional supplement ... sitting in the Northern District of Texas ... Glycoproducts International, Inc.,committed patent infringement of two ... Mannatech,s AMBROTOSE(R) technology., The jury ruled ...
... ANGELES, May 28 5-year-old Noor came to,the attention ... 1st,Battalion, 30th Infantry Regiment, 2nd Brigade Combat Team through ... resulted,in the death of the little girl,s uncle. The ... surgeon, concluded that Noor is blind,due to a birth ...
... standards and the life style connected to them seem ... symptoms. This has lead to the assumption that the ... structures or to exogenous non-infectious proteins, i.e. allergens, when ... protect the individual from infections. , The European ...
Other Medicine News:Health News:Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017 2Health News:Scientists Break Into HIV 'Hideout' 2Health News:Caritas Christi Standardizes on rL Solutions to Help Deliver Best in Class Healthcare Quality 2Health News:Jury Rules in Favor of Glycoproducts International, Inc. 2Health News:Photos: Los Angeles Non Profit Teams With US Troops Stationed in Baghdad and Buaytha in Bringing a 5-Year-Old Blind Iraqi Girl, Whose Father Stands Beside US Combat Team Against Al Qaeda, to the US for a Groundbreaking Artificial Corneal Transplant Surger 2Health News:Researchers from 5 countries to test hygiene hypothesis with EU funding 2
(Date:5/22/2012)... Serbia, May 22, 2012 Sorbent Therapeutics, ... and renal diseases, presented positive data from its ... study of 111 heart failure patients with chronic ... symptoms as compared to placebo.    ... were presented in an oral session at the ...
(Date:5/22/2012)... -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based ... Human Immunodeficiency Virus (HIV) infections, today announced that ... opened enrollment for a Phase 1 trial for ... is identical to the first generation ... for the inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) ...
(Date:5/22/2012)...   USANA Health Sciences , Inc. (NYSE: ... announced the promotion of Dr. John Cuomo to executive ... Dixon to executive director of new product and technological ... Mark Levy, a Ph.D. in human nutrition, and John ... professor at the University of Utah, have joined USANA,s ...
Breaking Medicine Technology:Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4USANA Health Sciences Expands Award-Winning Research and Development Team 2USANA Health Sciences Expands Award-Winning Research and Development Team 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 1Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 2Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 4PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes 20044 1PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes 20044 2Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 1Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 2Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 3
... week ARTEMIS data presented at ICAAC -, ... today from a phase 3, randomized, open-label, ongoing ... infected adults,taking PREZISTA(R) 800 mg (two 400 mg ... an undetectable viral load (<50 copies/mL) at week ...
... Phase III studies affirmed the clinical benefits of,ACTEMRA ... from two Phase III studies,showed that patients who ... arthritis (RA) achieved significant improvements in signs and,symptoms ... combination,with methotrexate compared with methotrexate alone. The final ...
Other Medicine Technology:Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 2ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 3ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 4ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 5ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: